SCHEMBL17091476

SCHEMBL17091476

CCCCCCCC/C=C\CCCCCCCCO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1N

nearest known ligand 0.65

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
▸ MAPK1 P28482 1/20 0.54
▸ CETP P11597 1/20 0.54
▸ GJB2 P29033 4/20 0.47
▸ GBA1 P04062 1/20 0.45
▸ SLC2A1 P11166 1/20 0.42
▸ LGALS8 O00214 1/20 0.42
▸ LGALS3 P17931 1/20 0.42
▸ LGALS4 P56470 1/20 0.42
▸ SELP P16109 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17091452 1.00 MAPK1 (0.54) MAPK1CETPGJB2GBA1SLC2A1
SCHEMBL17091453 1.00 MAPK1 (0.54) MAPK1CETPGJB2GBA1SLC2A1
SCHEMBL16250422 0.92 MAPK1 (0.61) MAPK1CETPGJB2GBA1LGALS8
SCHEMBL28995607 0.92 MAPK1 (0.61) MAPK1CETPGJB2GBA1LGALS8
SCHEMBL28364147 0.92 MAPK1 (0.61) MAPK1CETPGJB2GBA1LGALS8
SCHEMBL28264760 0.92 MAPK1 (0.61) MAPK1CETPGJB2GBA1LGALS8
SCHEMBL17640864 0.92 MAPK1 (0.61) MAPK1CETPGJB2GBA1LGALS8
Hydrochloric Acid SCHEMBL9403705 0.91 MAPK1 (0.60) MAPK1CETPGJB2GBA1LGALS8
Hydrochloric Acid SCHEMBL9403706 0.91 MAPK1 (0.60) MAPK1CETPGJB2GBA1LGALS8
SCHEMBL8614698 0.91 MAPK1 (0.59) MAPK1CETPGJB2GBA1LGALS8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2921179-A1 Micellar nanoparticles containing antitumoral glycosides Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC) (ES) 2015-09-23 — — EP claimed
EP-2921179-A1 Micellar nanoparticles containing antitumoral glycosides Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC) (ES) 2015-09-23 — — EP disclosed
Send feedback